APA (7th ed.) Citation

VM, N., SA, B., M, A., BR, K., ND, S., LG, G., . . . CPN, D. (2024). Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial. The Journal of urology, 212(1), 74. https://doi.org/10.1097/JU.0000000000004020

Chicago Style (17th ed.) Citation

VM, Narayan, et al. "Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial." The Journal of Urology 212, no. 1 (2024): 74. https://doi.org/10.1097/JU.0000000000004020.

MLA (9th ed.) Citation

VM, Narayan, et al. "Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial." The Journal of Urology, vol. 212, no. 1, 2024, p. 74, https://doi.org/10.1097/JU.0000000000004020.